Umeå universitets logga

umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Registration of histopathology to magnetic resonance imaging of prostate cancer
Umeå universitet, Medicinska fakulteten, Institutionen för strålningsvetenskaper, Radiofysik.ORCID-id: 0000-0001-8890-241x
Umeå universitet, Medicinska fakulteten, Institutionen för strålningsvetenskaper, Radiofysik.
Umeå universitet, Medicinska fakulteten, Institutionen för strålningsvetenskaper, Radiofysik.
Umeå universitet, Medicinska fakulteten, Institutionen för strålningsvetenskaper, Diagnostisk radiologi.
Visa övriga samt affilieringar
2021 (Engelska)Ingår i: Physics and Imaging in Radiation Oncology, E-ISSN 2405-6316, Vol. 18, s. 19-25Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Background and purpose: The diagnostic accuracy of new imaging techniques requires validation, preferably by histopathological verification. The aim of this study was to develop and present a registration procedure between histopathology and in-vivo magnetic resonance imaging (MRI) of the prostate, to estimate its uncertainty and to evaluate the benefit of adding a contour-correcting registration.

Materials and methods: For twenty-five prostate cancer patients, planned for radical prostatectomy, a 3D-printed prostate mold based on in-vivo MRI was created and an ex-vivo MRI of the specimen, placed inside the mold, was performed. Each histopathology slice was registered to its corresponding ex-vivo MRI slice using a 2D-affine registration. The ex-vivo MRI was rigidly registered to the in-vivo MRI and the resulting transform was applied to the histopathology stack. A 2D deformable registration was used to correct for specimen distortion concerning the specimen's fit inside the mold. We estimated the spatial uncertainty by comparing positions of landmarks in the in-vivo MRI and the corresponding registered histopathology stack.

Results: Eighty-four landmarks were identified, located in the urethra (62%), prostatic cysts (33%), and the ejaculatory ducts (5%). The median number of landmarks was 3 per patient. We showed a median in-plane error of 1.8 mm before and 1.7 mm after the contour-correcting deformable registration. In patients with extraprostatic margins, the median in-plane error improved from 2.1 mm to 1.8 mm after the contour-correcting deformable registration.

Conclusions: Our registration procedure accurately registers histopathology to in-vivo MRI, with low uncertainty. The contour-correcting registration was beneficial in patients with extraprostatic surgical margins.

Ort, förlag, år, upplaga, sidor
Elsevier, 2021. Vol. 18, s. 19-25
Nyckelord [en]
Histopathology correlation, Image registration, PET/MRI, Prostate cancer
Nationell ämneskategori
Radiologi och bildbehandling
Identifikatorer
URN: urn:nbn:se:umu:diva-182584DOI: 10.1016/j.phro.2021.03.004ISI: 000662270600004Scopus ID: 2-s2.0-85104070374OAI: oai:DiVA.org:umu-182584DiVA, id: diva2:1548242
Tillgänglig från: 2021-04-29 Skapad: 2021-04-29 Senast uppdaterad: 2023-09-05Bibliografiskt granskad
Ingår i avhandling
1. PET and MR imaging in prostate cancer
Öppna denna publikation i ny flik eller fönster >>PET and MR imaging in prostate cancer
2022 (Engelska)Doktorsavhandling, sammanläggning (Övrigt vetenskapligt)
Alternativ titel[sv]
PET och MR avbildning vid prostatacancer
Abstract [en]

The current risk assessment of prostate cancer (PC) relies on histopathological samples from biopsies and clinical variables such as prostate-specific antigen (PSA). However, this comes with uncertainties and in some cases it can be challenging to separate patients who would benefit from radical treatment and those who would not. The risk assessment tools for PC need to be improved and preferably developed into predictive markers. Medical imaging using positron emission tomography (PET) and magnetic resonance imaging (MRI) are potential diagnostic modalities for achieving such improvements. Both PET and MRI have several clinical applications in PC already and are increasingly being incorporated at different steps in the clinical management. For example, MRI is used to guide targeted biopsies, and also as a guide during planning of external beam radiotherapy treatments with focal boosting of the macroscopic visible tumour. However, more precise and individual treatment strategies demand verification of both the characterisation regarding aggressiveness and spatial distribution of the disease. 

To evaluate the performance of PET and MRI in detection of biochemical recurrent PC after radical prostatectomy, a systematic literature review was conducted (study I). The results of this systematic review indicated that there is a large variety of available imaging methods for PC being used for detecting local and/or locoregional recurrence. Many of the included studies were based on evaluation of patients with high PSA levels yielding high sensitivities and specificities. A pooled mean sensitivity was calculated to 84% for multiparametric MRI (mpMRI) and Choline-PET/CT. Methodological variations between and within studies were observed which limited the possibility of performing a meaningful meta-analysis. No publications evaluating radiotracers binding to prostate-specific membrane antigen (PSMA) were included in the review, although the early literature of using PSMA-PET showed much promise. 

To introduce a PSMA-binding radiotracer to the clinical management of PC at Umeå University Hospital a clinical trial was performed with the aim to investigate the clinical performance of the radiotracer [68Ga]PSMA-11. In this clinical trial we aimed to both evaluate the diagnostic performance and the safety of the radiotracer. To evaluate the safety, regarding radiation-exposure, absorbed organ doses as well as the effective dose were calculated in a cohort of six low-risk PC patients (study II). The results showed that the effective dose for [68Ga]PSMA-11 was 0.022 mSv/MBq, and that the kidneys and lacrimal glands were the organs receiving the highest organ doses. Based on these results, which were in line with other clinically used radiotracers, we could conclude that [68Ga]PSMA-11 is, from a radiation dosimetry perspective, a safe radiotracer to inject into patients. 

The diagnostic performance, specifically regarding detection of intraprostatic tumours using [68Ga]PSMA-11 (PSMA)-PET, mpMRI and [11C]Acetate (ACE)-PET was evaluated in a cohort of 55 intermediate and high-risk PC patients planned for radical prostatectomy with the whole mount histopathology as the reference test (study IV). The imaging modalities were radiologically reviewed and compared. Sensitivity regarding detection of intraprostatic lesions was calculated for each imaging modality. Regarding detection of lesions with a volume >0.5 cc and with a ISUP grade ≥2, PSMA-PET and mpMRI showed similar performance with sensitivities of 69% and 73%, respectively while ACE-PET had a sensitivity of 36%. 

In this clinical study, a registration procedure between histopathology and in vivo images was developed and performed in all patients. This procedure included both a 3D printed patient-specific prostate-mould, an ex vivo MRI of the specimen and image registrations (study III). The uncertainty of the precision of the registration between histopathology data and in vivo data was evaluated by comparing positions of landmarks visible in the corresponding images. The uncertainty of the method was estimated to a median in-plane error of 1.7 mm [interquartile range: 1.0, 2.5] for the entire registration procedure. 

To conclude, the tools for risk assessment of PC need to be improved and developed into predictive markers. When in vivo data is correlated with histopathology data, such as the data set collected within this thesis, it is possible to identify new predictive markers that can be used to improve the clinical management of PC. 

Ort, förlag, år, upplaga, sidor
Umeå: Umeå universitet, 2022. s. 72
Serie
Umeå University medical dissertations, ISSN 0346-6612 ; 2181
Nyckelord
PET, PSMA, MRI, PET/MRI, imaging, prostate cancer, intraprostatic tumour detection
Nationell ämneskategori
Radiologi och bildbehandling
Forskningsämne
radiofysik
Identifikatorer
urn:nbn:se:umu:diva-194419 (URN)978-91-7855-777-6 (ISBN)978-91-7855-778-3 (ISBN)
Disputation
2022-05-27, Bergasalen, Norrlands Universitetssjukhus, Umeå, 09:00 (Engelska)
Opponent
Handledare
Forskningsfinansiär
Cancerforskningsfonden i Norrland
Tillgänglig från: 2022-05-06 Skapad: 2022-05-04 Senast uppdaterad: 2022-05-05Bibliografiskt granskad

Open Access i DiVA

fulltext(3220 kB)261 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 3220 kBChecksumma SHA-512
a7682ee795453b7668faa59954d6f13ed30004db68bfc9863a1d09ffcb2652230842065231beffeb345b8757eed27bc1c20526c7d3ac2c771dd7f89ddc95426e
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextScopus

Person

Sandgren, KristinaNilsson, ErikKeeratijarut Lindberg, AngsanaStrandberg, SaraBergh, AndersFriedrich, BengtAxelsson, JanÖgren, MargaretaÖgren, MattiasWidmark, AndersThellenberg-Karlsson, CamillaSöderström, KarinRiklund, KatrineJonsson, JoakimNyholm, Tufve

Sök vidare i DiVA

Av författaren/redaktören
Sandgren, KristinaNilsson, ErikKeeratijarut Lindberg, AngsanaStrandberg, SaraBergh, AndersFriedrich, BengtAxelsson, JanÖgren, MargaretaÖgren, MattiasWidmark, AndersThellenberg-Karlsson, CamillaSöderström, KarinRiklund, KatrineJonsson, JoakimNyholm, Tufve
Av organisationen
RadiofysikDiagnostisk radiologiPatologiUrologi och andrologiOnkologi
I samma tidskrift
Physics and Imaging in Radiation Oncology
Radiologi och bildbehandling

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 263 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
urn-nbn

Altmetricpoäng

doi
urn-nbn
Totalt: 725 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf